Jade Biosciences is a pre-revenue biotech focused on JADE101 for IgA nephropathy, offering potential. Read why I rate JBIO ...
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today presented new global, real-world, patient-centric data, including data from a study assessing the impacts on quality of life ...
Scottish Medicines Consortium approves new NHS Scotland drugs for lung cancer, leukaemia, cervical cancer, pulmonary ...
Three cancer drugs and a new eczema medication are among the pharmaceuticals that a medical body has accepted for use by NHS ...
Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...
Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.
RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...
As altitude increases and oxygen levels drop, climbers on Kilimanjaro face physiological risks that can turn a straightforward hike into a dangerous situation.
Most patients with CHF must seek medical advice from healthcare professionals before planning travel, particularly if they have recently undergone cardiac surgery or have left ventricular assist ...